Facial lipoatrophy may be one of the manifestations of HIV-associated lipodystrophy in patients treated with protease inhibitors. The authors are from the University of British Columbia in Vancouver.
(1) degree of atrophy of subcutaneous fat
(2) prominence of facial musculature
Atrophy of Subcutaneous Fat
Prominence of Facial Muscles
minimal to mild
moderate (deeper and longer central cheek atrophy)
zygomasticus major and other facial muscles beginning to show
marked but not widespread
clearly present but not widespread
marked and widespread, extending to the orbits, with no subcutaneous fat
clearly present over a wide area
To read more or access our algorithms and calculators, please log in or register.
Specialty: Endocrinology, Clinical Laboratory, Infectious Diseases